PRECIGEN, INC. - Common Stock (PGEN)

Historical Holders from Q1 2016 to Q1 2025

Symbol
PGEN on Nasdaq
CUSIP
74017N105
Type / Class
Equity / Common Stock
Shares outstanding
271M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
75.7M
Holdings value
$84.7M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
128
Number of buys
58
Number of sells
-45
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PRECIGEN, INC. - Common Stock (PGEN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Patient Capital Management, LLC 6.53% $30.8M 17.7M Patient Capital Management, LLC Dec 31, 2024

Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.08M $1.6M -$403K $1.49 9
2024 Q4 75.7M $84.7M +$1.03M $1.12 128
2024 Q3 74.9M $71M +$14M $0.95 124
2024 Q2 60.7M $95.9M -$1.32M $1.58 130
2024 Q1 61.4M $89.1M -$836K $1.45 128
2023 Q4 62.3M $83.5M +$2.05M $1.34 132
2023 Q3 60.3M $85.7M +$4.91M $1.42 132
2023 Q2 57.4M $66M -$3.64M $1.15 135
2023 Q1 61.5M $65.1M +$19.8M $1.06 153
2022 Q4 42.2M $64.1M -$61.6K $1.52 153
2022 Q3 124M $262M -$18.5M $2.12 146
2022 Q2 134M $180M -$10.3M $1.34 150
2022 Q1 142M $299M +$573K $2.11 154
2021 Q4 135M $499M +$13.7M $3.71 152
2021 Q3 138M $689M -$19M $4.99 159
2021 Q2 142M $925M +$582K $6.52 140
2021 Q1 134M $926M +$133M $6.89 149
2020 Q4 120M $1.23B -$21.7M $10.20 138
2020 Q3 116M $407M +$6.75M $3.50 140
2020 Q2 121M $606M -$28.5M $4.99 140
2020 Q1 121M $412M +$411M $3.40 127
2019 Q4 159K $915K +$636K $5.48 3
2019 Q3 42.9K $279K $0 $6.51 1
2019 Q2 42.9K $279K $0 $6.51 1
2019 Q1 42.9K $279K $0 $6.51 1
2016 Q2 0 $0 -$12.7K 0
2016 Q1 375 $12.7K $0 $33.89 1